/APTCF
APTCF Stock - Advanced Proteome Therapeutics Corporation
Healthcare|BiotechnologyOTC
$0.00+0.00%
+$0.00 (+0.00%) • May 15
60
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.64
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for APTCF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.41
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-4,597 | $-2,956 | $-3,258 | $-4,216 | $-5,703 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-940,859 | $-650,508 | $-569,938 | $-926,000 | $-1,100,000 |
| Net Income | $759,615 | $-1,834,556 | $-450,636 | $-333,000 | $-745,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $0.02 | $-0.06 | $-0.02 | $-0.02 | $-0.05 |
Company Overview
Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. The company is headquartered in Burnaby, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
APTCFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.04
Q2 2023
EPS Surprise History
Q3 21
No data
Q4 21
No data
Q1 22
No data
Q2 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2024 | Jun 28, 2024 | — | — | — | — |
Q1 2024 | Mar 25, 2024 | — | — | — | — |
Q1 2024 | Jan 3, 2024 | — | — | — | — |
Q4 2023 | Oct 30, 2023 | — | — | — | — |
Q2 2023 | Jun 29, 2023 | — | $-0.04 | — | — |
Q1 2023 | Mar 28, 2023 | — | $-0.01 | — | — |
Q4 2022 | Dec 21, 2022 | — | $-0.01 | — | — |
Q3 2022 | Jul 31, 2022 | — | $-0.00 | — | — |
Q2 2022 | Apr 30, 2022 | — | $-0.01 | — | — |
Q1 2022 | Jan 31, 2022 | — | $0.02 | — | — |
Q4 2021 | Oct 31, 2021 | — | $0.02 | — | — |
Q3 2021 | Jul 31, 2021 | — | $0.00 | — | — |
Q2 2021 | Apr 30, 2021 | — | $-0.05 | — | — |
Q1 2021 | Jan 31, 2021 | — | $0.00 | — | — |
Q4 2020 | Oct 31, 2020 | — | $-0.01 | — | — |
Q3 2020 | Jul 31, 2020 | — | $-7.77 | — | — |
Q2 2020 | Apr 30, 2020 | — | $-0.01 | — | — |
Q1 2020 | Jan 31, 2020 | — | $-0.01 | — | — |
Q4 2019 | Oct 31, 2019 | — | $-0.00 | — | — |
Q3 2019 | Jul 31, 2019 | — | $-11.10 | — | — |
Latest News
Loading news...
Frequently Asked Questions about APTCF
What is APTCF's current stock price?
Advanced Proteome Therapeutics Corporation (APTCF) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for APTCF?
No analyst price targets are currently available for this stock.
What sector is Advanced Proteome Therapeutics Corporation in?
Advanced Proteome Therapeutics Corporation operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is APTCF's market cap?
Advanced Proteome Therapeutics Corporation has a market capitalization of $0.00 billion, making it a small-cap company.
Does APTCF pay dividends?
No, Advanced Proteome Therapeutics Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALDNF
Aladdin Healthcare Technologies SE
$0.01
Mkt Cap: $0.0B
EDNEF
Eden Empire Inc.
$0.00
Mkt Cap: $0.0B
HOPHF
Hemogenyx Pharmaceuticals Plc
$2.33
Mkt Cap: $0.0B
HURA
TuHURA Biosciences, Inc.
$0.82
Mkt Cap: $0.0B
MMNFF
MedMen Enterprises Inc.
$0.00
Mkt Cap: $0.0B
PPCB
Propanc Biopharma, Inc.
$0.71
Mkt Cap: $0.0B
PRED
Predictive Technology Group, Inc.
$0.00
Mkt Cap: $0.0B
PVTTF
Pivotal Therapeutics Inc.
$0.00
Mkt Cap: $0.0B
SNDD
RedHawk Holdings Corp.
$0.00
Mkt Cap: $0.0B
TCON
TRACON Pharmaceuticals, Inc.
$0.03
Mkt Cap: $0.0B
Explore stocks similar to APTCF for comparison